Platelet-to-White Blood Cell Ratio as a Predictor of Mortality in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2021;73(11):e4208–e4213. doi:10.1093/cid/ciaa270
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Srichatrapimuk S, Jayanama K, Kirdlarp S, et al. Predictors of pneumonia and severe pneumonia in patients with coronavirus disease 2019 at a tertiary-care hospital, Thailand. Southeast Asian J Trop Med Public Health. 2020;51(4):507–517.
   Web of Science ®Google Scholar
• Mahendra M, Nuchin A, Kumar R, Shreedhar S, Mahesh PA. Predictors of mortality in patients with severe COVID-19 pneumonia - A retrospective study. Adv Respir Med. 2021;89(2):135–144. doi:10.5603/ARM.a2021.0036
   PubMed Web of Science ®Google Scholar
• Mas-Ubillus G, Ortiz PJ, Huaringa-Marcelo J, et al. High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: a single centre retrospective cohort study. PLoS One. 2022;17(3):e0265089. doi:10.1371/journal.pone.0265089
   PubMed Web of Science ®Google Scholar
• Brandão Neto RA, Marchini JF, Marino LO, et al. Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: a prospective observational Brazilian study. PLoS One. 2021;16(1):e0244532.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028. doi:10.1515/cclm-2020-0369
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19 Clinical management: living guidance; 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1. Accessed November, 11, 2022.
   Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT; The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi:10.1136/thorax.58.5.377
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians. National early warning score (NEWS) 2; 2017. Available from: https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2. Accessed January, 2, 2023.
   Google Scholar
• Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089. doi:10.1001/jamainternmed.2020.2033
   PubMed Web of Science ®Google Scholar
• Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ. 2020;370:m3339. doi:10.1136/bmj.m3339
   PubMed Web of Science ®Google Scholar
• Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14–17.
   PubMedGoogle Scholar
• Yamada T, Wakabayashi M, Yamaji T, et al. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): a systematic review and meta-analysis. Clin Chim Acta. 2020;509:235–243. doi:10.1016/j.cca.2020.06.008
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang B, Xia H, et al. Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases. Epidemiol Infect. 2020;148:e199. doi:10.1017/S0950268820002010
   PubMed Web of Science ®Google Scholar
• Zhu B, Feng X, Jiang C, et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis. 2021;21(1):574. doi:10.1186/s12879-021-06277-3
   PubMed Web of Science ®Google Scholar
• Palladino M. Complete blood count alterations in COVID-19 patients: a narrative review. Biochem Med. 2021;31(3):030501. doi:10.11613/BM.2021.030501
   Web of Science ®Google Scholar
• Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233. doi:10.1016/j.carpath.2020.107233
   PubMed Web of Science ®Google Scholar
• Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020;8(1):37. doi:10.1186/s40364-020-00217-0
   PubMed Web of Science ®Google Scholar
• Huang W, Berube J, McNamara M, et al. Lymphocyte subset counts in COVID-19 patients: a meta-analysis. Cytometry A. 2020;97(8):772–776. doi:10.1002/cyto.a.24172
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020;31(4):490–496. doi:10.1080/09537104.2020.1754383
   PubMed Web of Science ®Google Scholar
• Aly MM, Meshref TS, Abdelhameid MA, et al. Can hematological ratios predict outcome of COVID-19 patients? A multicentric study. J Blood Med. 2021;12:505–515. doi:10.2147/JBM.S316681
   PubMed Web of Science ®Google Scholar
• Kilercik M, Demirelce Ö, Serdar MA, Mikailova P, Serteser M. A new haematocytometric index: predicting severity and mortality risk value in COVID-19 patients. PLoS One. 2021;16(8):e0254073. doi:10.1371/journal.pone.0254073
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206. doi:10.1186/s12967-020-02374-0
   PubMed Web of Science ®Google Scholar
• Lian J, Jin C, Hao S, et al. High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study. Aging. 2020;12(14):13849–13859. doi:10.18632/aging.103582
   PubMedGoogle Scholar
• Yildiz H, Castanares-Zapatero D, Pierman G, et al. Validation of neutrophil-to-lymphocyte ratio cut-off value associated with high in-hospital mortality in COVID-19 patients. Int J Gen Med. 2021;14:5111–5117. doi:10.2147/IJGM.S326666
   PubMed Web of Science ®Google Scholar
• Yildiz H, Castanares-Zapatero D, Hannesse C, Vandermeersch D, Pothen L, Jc Y. Prospective validation and comparison of COVID-GRAM, NEWS2, 4C mortality score, CURB-65 for the prediction of critical illness in COVID-19 patients. Infect Dis. 2021;53(8):640–642. doi:10.1080/23744235.2021.1896777
   PubMed Web of Science ®Google Scholar
• Fu J, Kong J, Wang W, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China. Thromb Res. 2020;192:3–8. doi:10.1016/j.thromres.2020.05.006
   PubMed Web of Science ®Google Scholar
• Ye W, Chen G, Li X, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020;21(1):169. doi:10.1186/s12931-020-01428-7
   PubMed Web of Science ®Google Scholar
• Abensur Vuillaume L, Le Borgne P, Alamé K, et al. Neutrophil-to-lymphocyte ratio and early variation of NLR to predict in-hospital mortality and severity in ED Patients with SARS-CoV-2 infection. J Clin Med. 2021;10(12):2563. doi:10.3390/jcm10122563
   PubMed Web of Science ®Google Scholar
• Weng J, Brown CV, Rhee P, et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma. 2005;59(5):1076–1080. doi:10.1097/01.ta.0000189001.00670.d2
   PubMedGoogle Scholar
• Zhang J, Qiu Y, He X, Mao W, Han Z. Platelet-to-white blood cell ratio: a novel and promising prognostic marker for HBV-associated decompensated cirrhosis. J Clin Lab Anal. 2020;34(12):e23556. doi:10.1002/jcla.23556
   PubMed Web of Science ®Google Scholar
• Guo J, Zhou B, Zhu M, et al. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study. Epidemiol Infect. 2020;148:e241. doi:10.1017/S0950268820002368
   PubMed Web of Science ®Google Scholar
• Bradley J, Sbaih N, Chandler TR, Furmanek S, Ramirez JA, Cavallazzi R. Pneumonia severity index and CURB-65 score are good predictors of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia. Chest. 2022;161(4):927–936. doi:10.1016/j.chest.2021.10.031
   PubMed Web of Science ®Google Scholar